Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FL.13.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GV.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HH.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EM.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FD.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GF.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.24NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FU.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.4.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GY.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.64 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.46.4 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.107 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.81 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.117 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.118 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.27 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.617.2 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.67 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.110 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.39.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.1.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.20NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.43.4 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.57 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.17NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.1.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.1.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.3.3 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.28.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.7.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.4.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.65NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.39.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDQ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.4.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.7.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDK.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.4.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.26NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.37NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JQ.2.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.23.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DY.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used